Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma

Anticancer Research

Volumn 32, Issue 2, 2012, Pages 681-686

  Komatsu, Masanori ^a   Tsukuda, Mamoru ^a   Matsuda, Hideki ^a   Horiuchi, Choichi ^a   Taguch, Takahide ^a   Takahashi, Masahiro ^a   Nishimura, Gohshi ^a   Mori, Makiko ^a   Niho, Tatuo ^a   Ishitoya, Junichi ^b   Sakuma, Yasunori ^b   Hirama, Mariko ^b   Shiono, Osamu ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

5 fluorouracil; Chemoradiotherapy; Cisplatin; Docetaxel; Nasopharyngeal carcinoma

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; DRUG EFFECT; FEMALE; FEVER; HUMAN; INDUCTION CHEMOTHERAPY; INTERMETHOD COMPARISON; MALE; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; INDUCTION CHEMOTHERAPY; LEUCOVORIN; MALE; METHOTREXATE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; RETROSPECTIVE STUDIES; TAXOIDS;

EID: 84856918008     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE and Ensley JF: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 16: 1310-1317, 1998. (Pubitemid 28175745)
2. Ma J, Mai HQ, Hong MH, Min HQ, Mao ZD, Cui NJ, Lu TX and Mo HY: Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J clin Oncol 19: 1350-1357, 2001. (Pubitemid 32202540)
3. Hareyama M, Sakata K, Shirato H, Nishioka T, Nishio M, Suzuki K, Saitoh A, Oouchi A, Fukuda S and Himi T: A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer 15: 2217-2223, 2002. (Pubitemid 34411980)
4. Chi KH, Chang YC, Guo WY, Leung MJ, Shiau CY, Chen SY, Wang LW, Lai YL, Hsu MM, Lian SL, Chang CH, Liu TW, Chin YH, Yen SH, Perng CH and Chen KY: A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys 52: 1238-1244, 2002. (Pubitemid 34296484)
5. Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS and Wang WY; Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 15: 631-637, 2003.
6. Chan AT, Leung SF, Ngan RK, Teo PM, Lau WH, Kwan WH, Hui EP, Yiu HY, Yeo W, Cheung FY, Yu KH, Chiu KW, Chan DT, Mok TS, Yau S, Yuen KT, Mo FK, Lai MM, Ma BB, Kam MK, Leung TW, Johnson PJ, Choi PH and Zee BC: Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97: 536-539, 2005. (Pubitemid 40590436)
7. Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, Chua ET, Yang E, Lee KM, Fong KW, Tan HS, Lee KS, Loong S, Sethi V, Chua EJ and Machin D: Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and VI nasopharyngeal cancer of the endemic variety. J Clin Oncol 23: 6730-6738, 2005. (Pubitemid 46190268)
8. Lee AW, Tung SY, Chua DT, Ngan RK, Chappell R, Tung R, Siu L, Ng WT, Sze WK, Au GK, Law SC, O'Sullivan B, Yau TK, Leung TW, Au JS, Sze WM, Choi CW, Fung KK, Lau JT and Lau WH: Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs. radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 102: 1188-1198, 2010.
9. Taguchi T, Tsukuda M and Katori H: Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx. Acta Otolaryngol 126: 408-413, 2006.
10. Katori H, Tsukuda M and Taguchi T: Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 59(6): 789-794, 2007. (Pubitemid 46440602)
11. Taguchi T, Tsukuda M, Mikami Y, Matsuda H, Tanigaki Y, Horiuchi C, Nishimura G and Nagao J: Treatment results and prognosticfactors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Auris Nasus Larynx 36(2): 199-204, 2009.
12. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J and Lefebvre JL; EORTC 24971/TAX 323 Study Group: Cisplatin, fluorouracil, and decetaxel in unresectable head and neck cancer. N Eng J Med 357(17): 1695-1704, 2007.
13. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr. and Haddad RI; TAX 324 Study Group: Cisplatin and fluorouracil alone or with decetaxel in head and neck cancer. N Eng J Med 357(17): 1705-1715, 2007. (Pubitemid 350005152)
14. Tsukuda M, Mikami Y, Tanigaki Y, Katori H, Horiuchi C, Ikeda Y, Taguchi T, Ono M, Yoshida T, Sakuma Y and Aikoh K: Phase I trial of combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) for patients with locally locally advanced squamous cell carcinoma of the head and neck. Int J Clin Oncol 9: 161-166, 2004. (Pubitemid 38899748)
15. Katori H, Tsukuda M, Mochimatu I, Ishitoya J, Kawai S, Mikami Y, Matsuda H, Tanigaki Y, Horiuchi C, Ikeda Y, Taguchi T, Ono M, Yoshida T, Hirose S, Sakuma Y and Yamamoto K: Phase 1 trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (HNSCC). Br J Cancer 90: 348-352, 2004. (Pubitemid 38250627)
16. Katori H, Tsukuda M and Watai K: Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (HNSCC). Cancer Chemother Pharmacol 60(3): 399-406, 2007. (Pubitemid 46944577)
17. Tsukuda M, Ishitoya J, Matsuda H, Horiuchi C, Taguchi T, Takahashi M, Nishimura G, Kawakami M, Watanabe M, Niho T, Kawano T, Ikeda Y, Sakuma Y, Shiono O and Komatsu M: Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 66: 729-736, 2010.
18. Mori M, Tsukuda M, Matsuda H, Horiuchi C, Taguchi T, Takahashi M, Nishimura G, Komatsu M, Niho T, Sakuma N, Miyakoshi A, Isono Y and Iwahana S: Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinoma. Cancer Chemother Pharmacol 68: 855-862, 2011.
19. Barnes L, Eveson JW, Reichart P and Shidransky D: World Health Organization Classification of Tumours. Pathology and genetics of head and neck tumors. IARC Press: Lyon, pp. 85-97, 2005.
20. Hui EP, Ma BB, Leung SF, King AD, Mo F, Kam MK, Yu BK, Chiu SK, Kwan WH, Ho R, Chan I, Ahuja AT, Zee BC and Chan AT: Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol 27: 242-249, 2009.
21. Bae WK, Hwang JE, Shim HJ, Cho SH, Lee JK, Lim SC, Chung WK and Chung IJ: Phase II study of docetaxel, and 5-FU induction chemotherapy followed by the chemoradiotherapy in locoregionally advanced nasopharyngeal cancer. Cancer Chemother Pharmacol 65: 589-595, 2010.
22. Park KH, Kim JS, Park Y, Seo HY, Park YJ, Choi IK, Oh SC, Seo JH, Kim CY, Jung KY, Shin SW, Kim YH, Kim JS and Lee NJ: Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregional advanced nasopharyngeal carcinoma in Korea. Cancer Chemother Pharmacol 66(4): 643-651, 2010.